About
Technology
Issues
FAQ
Title
Abstract
Text
Figure Captions
Table Cells
Section Titles
Keywords
Subjects
Authors
From
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
2007
2006
2005
2004
2003
2002
2001
2000
1995
1990
1985
1980
1975
1970
1960
1950
1940
1930
1920
1910
1900
1850
1800
1700
1600
To
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
2007
2006
2005
2004
2003
2002
2001
2000
1995
1990
1985
1980
1975
1970
1960
1950
1940
1930
1920
1910
1900
1850
1800
1700
1600
All Types
Articles
Communications
Reviews
Discussions
Case Reports
Chapters
Books
News
Editorials
Order By
Order By Year ASC
Order By Year DESC
Order By Citations ASC
Order By Citations DESC
Go
Scientometrics
Impact Factor
Discipline Ranks
H-Index
G-Index
Articles
Citations
Article Citations
Citation Distribution
Search This Journal
Overviews
Top Institutions
Top Schools
Top Authors
Prolific Authors
Top Articles
exaly
›
Journals
›
European Journal of Pharmaceutical Sciences
›
Top Articles
European Journal of Pharmaceutical Sciences
Pharmacology
5.1
(top 3%)
Impact Factor
5.4
(top 3%)
extended IF
140
(top 2%)
H-Index
5.3K
authors
5.9K
papers
174.8K
citations
6.3K
citing journals
77K
citing authors
Most Cited Articles of European Journal of Pharmaceutical Sciences
Title
Year
Citations
Modeling and comparison of dissolution profiles
2001
3.4K
Nanosizing: a formulation approach for poorly-water-soluble compounds
2003
975
Novel mechanisms and devices to enable successful transdermal drug delivery
2001
838
Formulation of poorly water-soluble drugs for oral administration: physicochemical and physiological issues and the lipid formulation classification system
2006
835
Multidrug resistance (MDR) in cancer. Mechanisms, reversal using modulators of MDR and the role of MDR modulators in influencing the pharmacokinetics of anticancer drugs
2000
833
Lipid formulations for oral administration of drugs: non-emulsifying, self-emulsifying and 'self-microemulsifying' drug delivery systems
2000
787
Nanoparticle encapsulation improves oral bioavailability of curcumin by at least 9-fold when compared to curcumin administered with piperine as absorption enhancer
2009
678
Transport of drugs from the nasal cavity to the central nervous system
2000
657
Drug targeting
2000
589
A review of current nanoparticle and targeting moieties for the delivery of cancer therapeutics
2013
546
Development of a nanoprecipitation method intended for the entrapment of hydrophilic drugs into nanoparticles
2005
503
The ABCs of drug transport in intestine and liver: efflux proteins limiting drug absorption and bioavailability
2004
482
Gene delivery by lipoplexes and polyplexes
2010
471
Pharmacological properties of the ubiquitous natural product betulin
2006
470
Liposomes and skin: from drug delivery to model membranes
2008
442
Transporters as a determinant of drug clearance and tissue distribution
2006
425
In vitro-in vivo correlations for lipophilic, poorly water-soluble drugs
2000
409
Human hepatocyte culture systems for the in vitro evaluation of cytochrome P450 expression and regulation
2001
403
Synthesis, antibacterial, antifungal and anti-HIV activities of Schiff and Mannich bases derived from isatin derivatives and N-[4-(4'-chlorophenyl)thiazol-2-yl] thiosemicarbazide
1999
403
Optimized conditions for prediction of intestinal drug permeability using Caco-2 cells
2000
397
Effects of nonionic surfactants on membrane transporters in Caco-2 cell monolayers
2002
395
Dendrimers: emerging polymers for drug-delivery systems
2009
392
Microencapsulated chitosan nanoparticles for lung protein delivery
2005
371
The applications of Vitamin E TPGS in drug delivery
2013
368
When poor solubility becomes an issue: from early stage to proof of concept
2007
367
0
1
2
next
How are inpact factors calculated?
The impact factor (IF) is calculated by counting citations from peer-reviewed journals only.
extended IF
also counts citations from books and conference papers. However, no patent, abstract, working papers, online documents, etc., are covered.
site/software ©
exaly
; All materials licenced under
CC by-SA
.